http://www.outlooktherapeutics.com
Outlook Therapeutics, Inc. Company Intro
NEWS JULY 17, 2020
Outlook Therapeutics Announces Closing of $1.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules More JULY 7, 2020
Outlook Therapeutics Completes Patient Enrollment for NORSE 2 Study of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) More
Industry
Healthcare
Outlook Therapeutics, Inc. Headquaters
7 Clarke Drive
Cranbury,08512
United States
Outlook Therapeutics, Inc. Share price
26 Oct 2020 02:16 GMT
$0.7450
0.0 (0.59 %)
Outlook Therapeutics, Inc. Market cap
$101.759 M
WMC RANKING
2020
Outlook Therapeutics, Inc. # 166
BiotechnologyLatest Outlook Therapeutics, Inc. News
26 Oct 2020
Hepatitis Therapeutics Market Outlook 2020: Global Topmost ...
Hepatitis Therapeutics Market Outlook 2020: Global Topmost Companies, ... of the company executives and representatives and accessing official documents, ...
26 Oct 2020
Global Sandhoff Disease Therapeutics Market Opportunities, Outlook, Product types and Compatitive Analysis by 2026| Bioasis Technologies Inc, Nuo Therapeutics Inc
Global Sandhoff Disease Therapeutics Market Opportunities, Outlook, Product types and Compatitive Analysis by 2026| Bioasis Technologies Inc, Nuo ...
26 Oct 2020
What Is the Outlook For Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) Like For Short-Term?
What Is the Outlook For Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) Like For Short-Term? By. Nora Atcheson. -. October 26, 2020. 0. 18.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Outlook Therapeutics, Inc. | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.29 | 100 | 20 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.09 | 26 | 0 | 0 | 97.35 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 2.78 |
| Incyte Corporation | 40.27 | 14.26 | 7.21 | 100 | 0 | 0 | 90.91 |
Outlook Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Outlook Therapeutics, Inc. | $6,437 | $30,939 | $-50,795 | $101.759M | 166 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.654B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.11B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.42B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.615B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Outlook Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Post vs Top 4 Industry Competitors
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
